Ginkgo Bioworks DNA Reportable Segment — Stock-Based Comp
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:EmployeeBenefitsAndShareBasedCompensation.
The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ginkgo Bioworks's reportable segment — stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Ginkgo Bioworks's reportable segment — stock-based comp?
- Ginkgo Bioworks (DNA) reported reportable segment — stock-based comp of $16.71M in Q1 2026.
- What does reportable segment — stock-based comp mean?
- This represents the non-cash expense recognized for equity-based awards granted to employees within a specific business segment. It is an essential component for understanding the true cost of talent acquisition and retention relative to the segment's operational output.